Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
321.43
-7.58 (-2.30%)
At close: Apr 28, 2026, 4:00 PM EDT
322.45
+1.02 (0.32%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Company Description

Stryker Corporation operates as a medical technology company in the United States and internationally.

It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.

The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.

The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries.

Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Stryker Corporation
Stryker logo
Country United States
Founded 1941
Industry Medical Devices
Sector Healthcare
Employees 56,000
CEO Kevin Lobo

Contact Details

Address:
1941 Stryker Way
Portage, Michigan 49002
United States
Phone (269) 385-2600
Website stryker.com

Stock Details

Ticker Symbol SYK
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000310764
CUSIP Number 863667101
ISIN Number US8636671013
Employer ID 38-1239739
SIC Code 3841

Key Executives

Name Position
Kevin A. Lobo Chairman and Chief Executive Officer
Spencer S. Stiles President and Chief Operating Officer
Preston W. Wells Vice President and Chief Financial Officer
Viju S. Menon Group President of Global Quality and Operations
J. Andrew Pierce Group President of MedSurg and Neurotechnology
William E. Berry Jr. Vice President and Chief Accounting Officer
Robert C. Cohen Chief Technology Officer and Vice President of Global Research & Development - Joint Replacement
Debra S. King Vice President and Chief Digital and Information Officer
Robert S. Fletcher Vice President and Chief Legal Officer
Dana S. McMahon Vice President and Chief Compliance Officer

Latest SEC Filings

Date Type Title
Apr 14, 2026 SCHEDULE 13D/A Filing
Apr 9, 2026 8-K/A [Amend] Current report
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 23, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 23, 2026 DEF 14A Other definitive proxy statements
Mar 23, 2026 8-K Current Report
Mar 12, 2026 8-K Current Report
Mar 11, 2026 8-K Current Report
Feb 11, 2026 SCHEDULE 13G/A Filing
Feb 11, 2026 10-K Annual Report